Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR5 | P35346 | 5/20 | 0.67 |
| ▸ | SSTR1 | P30872 | 4/20 | 0.67 |
| ▸ | SSTR2 | P30874 | 4/20 | 0.67 |
| ▸ | SSTR4 | P31391 | 4/20 | 0.67 |
| ▸ | SSTR3 | P32745 | 4/20 | 0.67 |
| ▸ | BCHE | P06276 | 1/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.47 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.47 |
| ▸ | GJB2 | P29033 | 1/20 | 0.44 |
| ▸ | NT5E | P21589 | 1/20 | 0.44 |
| ▸ | CDC25B | P30305 | 2/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
| ▸ | TACR1 | P25103 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3467445 | 1.00 | SSTR5 (0.67) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL6879922 | 0.99 | SSTR5 (0.65) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL6879920 | 0.99 | SSTR5 (0.65) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL8152898 | 0.94 | SSTR5 (0.60) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL8152902 | 0.94 | SSTR5 (0.60) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL6383598 | 0.94 | SSTR5 (0.64) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL6893382 | 0.92 | SSTR5 (0.59) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL24122546 | 0.90 | SSTR1 (0.72) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL6298172 | 0.90 | SSTR1 (0.72) | SSTR5SSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL7148930 | 0.90 | SSTR1 (0.72) | SSTR5SSTR1SSTR2SSTR4SSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130164387-A9 | NOVEL MANNOPYRANOSIDE DERIVATIVES WITH ANTICANCER ACTIVITY | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2013-06-27 | — | — | US | disclosed |
| US-20120269903-A1 | NOVEL MANNOPYRANOSIDE DERIVATIVES WITH ANTICANCER ACTIVITY | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2012-10-25 | — | — | US | disclosed |
| US-20110112044-A1 | NOVEL USES OF D-MANNOPYRANOSE DERIVATIVES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130164387-A9 | NOVEL MANNOPYRANOSIDE DERIVATIVES WITH ANTICANCER ACTIVITY | MAN2A1, MANBA, MAN2B1 | SSTR5 3215/4885SSTR1 4137/4885SSTR2 3782/4885 |
| US-20110112044-A1 | NOVEL USES OF D-MANNOPYRANOSE DERIVATIVES | M6PR, BMP6, DCPS | SSTR5 1473/4885SSTR1 1791/4885SSTR2 2335/4885 |
| US-20120269903-A1 | NOVEL MANNOPYRANOSIDE DERIVATIVES WITH ANTICANCER ACTIVITY | MAN2A1, MANBA, MAN2B1 | SSTR5 3215/4885SSTR1 4137/4885SSTR2 3782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.